Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TFEC
|
ENSG00000105967.11 | transcription factor EC |
MITF
|
ENSG00000187098.10 | melanocyte inducing transcription factor |
ARNTL
|
ENSG00000133794.13 | aryl hydrocarbon receptor nuclear translocator like |
BHLHE41
|
ENSG00000123095.5 | basic helix-loop-helix family member e41 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFEC | hg19_v2_chr7_-_115670804_115670867 | -0.60 | 3.2e-04 | Click! |
MITF | hg19_v2_chr3_+_69811858_69811881 | 0.34 | 5.4e-02 | Click! |
ARNTL | hg19_v2_chr11_+_13299186_13299432 | -0.11 | 5.4e-01 | Click! |
BHLHE41 | hg19_v2_chr12_-_26278030_26278060 | 0.08 | 6.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_67039278 | 5.59 |
ENST00000276573.7
ENST00000350034.4 |
TRIM55
|
tripartite motif containing 55 |
chr8_+_67039131 | 5.04 |
ENST00000315962.4
ENST00000353317.5 |
TRIM55
|
tripartite motif containing 55 |
chr11_-_18343669 | 3.74 |
ENST00000396253.3
ENST00000349215.3 ENST00000438420.2 |
HPS5
|
Hermansky-Pudlak syndrome 5 |
chr1_-_154193091 | 3.55 |
ENST00000362076.4
ENST00000350592.3 ENST00000368516.1 |
C1orf43
|
chromosome 1 open reading frame 43 |
chr1_-_21995794 | 3.41 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr1_-_154193009 | 3.37 |
ENST00000368518.1
ENST00000368519.1 ENST00000368521.5 |
C1orf43
|
chromosome 1 open reading frame 43 |
chr11_-_18343725 | 3.30 |
ENST00000531848.1
|
HPS5
|
Hermansky-Pudlak syndrome 5 |
chr1_+_154193643 | 3.22 |
ENST00000456325.1
|
UBAP2L
|
ubiquitin associated protein 2-like |
chr12_-_58145889 | 3.10 |
ENST00000547853.1
|
CDK4
|
cyclin-dependent kinase 4 |
chr10_-_50970382 | 2.93 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
chr1_-_26394114 | 2.83 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
chr1_-_42921915 | 2.75 |
ENST00000372565.3
ENST00000433602.2 |
ZMYND12
|
zinc finger, MYND-type containing 12 |
chr10_-_50970322 | 2.68 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
chr11_+_18343800 | 2.55 |
ENST00000453096.2
|
GTF2H1
|
general transcription factor IIH, polypeptide 1, 62kDa |
chr13_-_44735393 | 2.47 |
ENST00000400419.1
|
SMIM2
|
small integral membrane protein 2 |
chr16_-_68269971 | 2.41 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
chr9_-_97356075 | 2.38 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
chrX_-_34675391 | 2.33 |
ENST00000275954.3
|
TMEM47
|
transmembrane protein 47 |
chr17_-_7197881 | 2.32 |
ENST00000007699.5
|
YBX2
|
Y box binding protein 2 |
chr11_-_45307817 | 2.10 |
ENST00000020926.3
|
SYT13
|
synaptotagmin XIII |
chr1_-_201368707 | 2.09 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr1_-_201368653 | 1.99 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr11_+_112038088 | 1.93 |
ENST00000530752.1
ENST00000280358.4 |
TEX12
|
testis expressed 12 |
chr19_-_5680891 | 1.91 |
ENST00000309324.4
|
C19orf70
|
chromosome 19 open reading frame 70 |
chr1_+_150254936 | 1.84 |
ENST00000447007.1
ENST00000369095.1 ENST00000369094.1 |
C1orf51
|
chromosome 1 open reading frame 51 |
chrX_-_102319092 | 1.77 |
ENST00000372728.3
|
BEX1
|
brain expressed, X-linked 1 |
chr11_+_18344106 | 1.72 |
ENST00000534641.1
ENST00000525831.1 ENST00000265963.4 |
GTF2H1
|
general transcription factor IIH, polypeptide 1, 62kDa |
chr1_+_154193325 | 1.71 |
ENST00000428931.1
ENST00000441890.1 ENST00000271877.7 ENST00000412596.1 ENST00000368504.1 ENST00000437652.1 |
UBAP2L
|
ubiquitin associated protein 2-like |
chr2_+_85981008 | 1.68 |
ENST00000306279.3
|
ATOH8
|
atonal homolog 8 (Drosophila) |
chr19_-_48018203 | 1.68 |
ENST00000595227.1
ENST00000593761.1 ENST00000263354.3 |
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha |
chr9_-_34048873 | 1.67 |
ENST00000449054.1
ENST00000379239.4 ENST00000539807.1 ENST00000379238.1 ENST00000418786.2 ENST00000360802.1 ENST00000412543.1 |
UBAP2
|
ubiquitin associated protein 2 |
chr19_-_40854417 | 1.64 |
ENST00000582006.1
ENST00000582783.1 |
C19orf47
|
chromosome 19 open reading frame 47 |
chr22_+_17956618 | 1.63 |
ENST00000262608.8
|
CECR2
|
cat eye syndrome chromosome region, candidate 2 |
chr8_-_107782463 | 1.54 |
ENST00000311955.3
|
ABRA
|
actin-binding Rho activating protein |
chr19_+_32836499 | 1.52 |
ENST00000311921.4
ENST00000544431.1 ENST00000355898.5 |
ZNF507
|
zinc finger protein 507 |
chr10_-_82049424 | 1.50 |
ENST00000372213.3
|
MAT1A
|
methionine adenosyltransferase I, alpha |
chr5_+_43602750 | 1.50 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
chr17_+_46018872 | 1.47 |
ENST00000583599.1
ENST00000434554.2 ENST00000225573.4 ENST00000544840.1 ENST00000534893.1 |
PNPO
|
pyridoxamine 5'-phosphate oxidase |
chr17_-_48450534 | 1.45 |
ENST00000503633.1
ENST00000442592.3 ENST00000225969.4 |
MRPL27
|
mitochondrial ribosomal protein L27 |
chr11_+_125774258 | 1.44 |
ENST00000263576.6
|
DDX25
|
DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
chr19_-_17375527 | 1.42 |
ENST00000431146.2
ENST00000594190.1 |
USHBP1
|
Usher syndrome 1C binding protein 1 |
chrX_+_10124977 | 1.40 |
ENST00000380833.4
|
CLCN4
|
chloride channel, voltage-sensitive 4 |
chr7_-_1595871 | 1.40 |
ENST00000319010.5
|
TMEM184A
|
transmembrane protein 184A |
chr11_+_77774897 | 1.40 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
chr1_-_31845914 | 1.38 |
ENST00000373713.2
|
FABP3
|
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
chr18_+_77867177 | 1.38 |
ENST00000560752.1
|
ADNP2
|
ADNP homeobox 2 |
chr3_-_126076264 | 1.34 |
ENST00000296233.3
|
KLF15
|
Kruppel-like factor 15 |
chr10_-_93392811 | 1.33 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
chr4_+_128651530 | 1.32 |
ENST00000281154.4
|
SLC25A31
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 |
chr5_+_173315283 | 1.29 |
ENST00000265085.5
|
CPEB4
|
cytoplasmic polyadenylation element binding protein 4 |
chr8_-_71581377 | 1.25 |
ENST00000276590.4
ENST00000522447.1 |
LACTB2
|
lactamase, beta 2 |
chr5_+_191592 | 1.25 |
ENST00000328278.3
|
LRRC14B
|
leucine rich repeat containing 14B |
chr9_+_133978190 | 1.23 |
ENST00000372312.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr8_-_75233563 | 1.22 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
chr22_-_50700140 | 1.21 |
ENST00000215659.8
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr16_-_70719925 | 1.19 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
chr4_-_23891693 | 1.18 |
ENST00000264867.2
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
chr12_+_50355647 | 1.18 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr6_+_151646800 | 1.17 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr1_-_217250231 | 1.15 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
chr1_+_110009215 | 1.15 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr5_+_43603229 | 1.15 |
ENST00000344920.4
ENST00000512996.2 |
NNT
|
nicotinamide nucleotide transhydrogenase |
chr12_-_111358372 | 1.15 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chr12_-_49393092 | 1.14 |
ENST00000421952.2
|
DDN
|
dendrin |
chr19_+_5681011 | 1.14 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
chr4_-_164253738 | 1.14 |
ENST00000509586.1
ENST00000504391.1 ENST00000512819.1 |
NPY1R
|
neuropeptide Y receptor Y1 |
chr22_-_36903101 | 1.13 |
ENST00000397224.4
|
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
chr19_-_8386238 | 1.11 |
ENST00000301457.2
|
NDUFA7
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa |
chr14_-_74551096 | 1.10 |
ENST00000350259.4
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
chr12_+_81110684 | 1.09 |
ENST00000228644.3
|
MYF5
|
myogenic factor 5 |
chr1_-_204329013 | 1.07 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
chrX_+_105937068 | 1.07 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr14_-_74551172 | 1.06 |
ENST00000553458.1
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
chr16_-_31439735 | 1.06 |
ENST00000287490.4
|
COX6A2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr11_+_33037401 | 1.06 |
ENST00000241051.3
|
DEPDC7
|
DEP domain containing 7 |
chr3_+_147127142 | 1.05 |
ENST00000282928.4
|
ZIC1
|
Zic family member 1 |
chr20_-_62130474 | 1.05 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr14_+_77564701 | 1.05 |
ENST00000557115.1
|
KIAA1737
|
CLOCK-interacting pacemaker |
chr1_+_207226574 | 1.05 |
ENST00000367080.3
ENST00000367079.2 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
chr17_+_79935418 | 1.03 |
ENST00000306729.7
ENST00000306739.4 |
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
chr10_-_32217717 | 1.03 |
ENST00000396144.4
ENST00000375245.4 ENST00000344936.2 ENST00000375250.5 |
ARHGAP12
|
Rho GTPase activating protein 12 |
chr11_+_62538775 | 1.02 |
ENST00000294168.3
ENST00000526261.1 |
TAF6L
|
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa |
chr9_-_131709858 | 1.01 |
ENST00000372586.3
|
DOLK
|
dolichol kinase |
chr12_-_63328817 | 1.00 |
ENST00000228705.6
|
PPM1H
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
chr6_+_31949801 | 1.00 |
ENST00000428956.2
ENST00000498271.1 |
C4A
|
complement component 4A (Rodgers blood group) |
chr6_+_31950150 | 1.00 |
ENST00000537134.1
|
C4A
|
complement component 4A (Rodgers blood group) |
chr17_-_48450265 | 0.99 |
ENST00000507088.1
|
MRPL27
|
mitochondrial ribosomal protein L27 |
chr15_-_72668185 | 0.98 |
ENST00000457859.2
ENST00000566304.1 ENST00000567159.1 ENST00000429918.2 |
HEXA
|
hexosaminidase A (alpha polypeptide) |
chr9_+_74764340 | 0.97 |
ENST00000376986.1
ENST00000358399.3 |
GDA
|
guanine deaminase |
chr16_-_23160591 | 0.96 |
ENST00000219689.7
|
USP31
|
ubiquitin specific peptidase 31 |
chr1_+_110009150 | 0.96 |
ENST00000401021.3
|
SYPL2
|
synaptophysin-like 2 |
chr2_-_220083671 | 0.96 |
ENST00000439002.2
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr11_+_107879459 | 0.95 |
ENST00000393094.2
|
CUL5
|
cullin 5 |
chr2_-_220083692 | 0.95 |
ENST00000265316.3
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr11_-_3663480 | 0.95 |
ENST00000397068.3
|
ART5
|
ADP-ribosyltransferase 5 |
chr6_+_31982539 | 0.95 |
ENST00000435363.2
ENST00000425700.2 |
C4B
|
complement component 4B (Chido blood group) |
chr17_+_79935464 | 0.94 |
ENST00000581647.1
ENST00000580534.1 ENST00000579684.1 |
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
chr2_+_240323439 | 0.94 |
ENST00000428471.1
ENST00000413029.1 |
AC062017.1
|
Uncharacterized protein |
chr8_-_33455268 | 0.94 |
ENST00000522982.1
|
DUSP26
|
dual specificity phosphatase 26 (putative) |
chr17_-_18266660 | 0.93 |
ENST00000582653.1
ENST00000352886.6 |
SHMT1
|
serine hydroxymethyltransferase 1 (soluble) |
chr2_-_176867534 | 0.93 |
ENST00000445472.1
|
KIAA1715
|
KIAA1715 |
chr10_-_90342947 | 0.93 |
ENST00000437752.1
ENST00000331772.4 |
RNLS
|
renalase, FAD-dependent amine oxidase |
chr1_-_222886526 | 0.93 |
ENST00000541237.1
|
AIDA
|
axin interactor, dorsalization associated |
chr11_+_125774362 | 0.93 |
ENST00000530414.1
ENST00000530129.2 |
DDX25
|
DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
chr19_-_17375541 | 0.93 |
ENST00000252597.3
|
USHBP1
|
Usher syndrome 1C binding protein 1 |
chr7_+_73868439 | 0.92 |
ENST00000424337.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
chr9_-_99801925 | 0.90 |
ENST00000538255.1
|
CTSV
|
cathepsin V |
chr11_-_3663502 | 0.90 |
ENST00000359918.4
|
ART5
|
ADP-ribosyltransferase 5 |
chr12_+_122356488 | 0.90 |
ENST00000397454.2
|
WDR66
|
WD repeat domain 66 |
chr11_-_47664072 | 0.90 |
ENST00000542981.1
ENST00000530428.1 ENST00000302503.3 |
MTCH2
|
mitochondrial carrier 2 |
chr14_-_81687197 | 0.90 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr3_+_184032283 | 0.89 |
ENST00000346169.2
ENST00000414031.1 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chr7_-_1595756 | 0.89 |
ENST00000441933.1
|
TMEM184A
|
transmembrane protein 184A |
chr9_+_12693336 | 0.88 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
chr17_+_55163075 | 0.88 |
ENST00000571629.1
ENST00000570423.1 ENST00000575186.1 ENST00000573085.1 ENST00000572814.1 |
AKAP1
|
A kinase (PRKA) anchor protein 1 |
chr12_+_123849462 | 0.88 |
ENST00000543072.1
|
hsa-mir-8072
|
hsa-mir-8072 |
chr11_+_22696314 | 0.88 |
ENST00000532398.1
ENST00000433790.1 |
GAS2
|
growth arrest-specific 2 |
chr12_-_123849374 | 0.87 |
ENST00000602398.1
ENST00000602750.1 |
SBNO1
|
strawberry notch homolog 1 (Drosophila) |
chrX_-_55020511 | 0.87 |
ENST00000375006.3
ENST00000374992.2 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr20_-_30458019 | 0.86 |
ENST00000486996.1
ENST00000398084.2 |
DUSP15
|
dual specificity phosphatase 15 |
chr19_-_12886327 | 0.86 |
ENST00000397668.3
ENST00000587178.1 ENST00000264827.5 |
HOOK2
|
hook microtubule-tethering protein 2 |
chr11_-_18270182 | 0.86 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
chr5_-_110074603 | 0.86 |
ENST00000515278.2
|
TMEM232
|
transmembrane protein 232 |
chr19_+_13049413 | 0.85 |
ENST00000316448.5
ENST00000588454.1 |
CALR
|
calreticulin |
chr14_-_68283291 | 0.85 |
ENST00000555452.1
ENST00000347230.4 |
ZFYVE26
|
zinc finger, FYVE domain containing 26 |
chr16_-_4292071 | 0.85 |
ENST00000399609.3
|
SRL
|
sarcalumenin |
chr19_-_5719860 | 0.85 |
ENST00000590729.1
|
LONP1
|
lon peptidase 1, mitochondrial |
chr19_-_5720123 | 0.85 |
ENST00000587365.1
ENST00000585374.1 ENST00000593119.1 |
LONP1
|
lon peptidase 1, mitochondrial |
chr4_-_109684120 | 0.84 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
chr7_+_116593536 | 0.84 |
ENST00000417919.1
|
ST7
|
suppression of tumorigenicity 7 |
chr19_-_40854281 | 0.83 |
ENST00000392035.2
|
C19orf47
|
chromosome 19 open reading frame 47 |
chr3_+_184032313 | 0.83 |
ENST00000392537.2
ENST00000444134.1 ENST00000450424.1 ENST00000421110.1 ENST00000382330.3 ENST00000426123.1 ENST00000350481.5 ENST00000455679.1 ENST00000440448.1 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chr8_-_54755459 | 0.83 |
ENST00000524234.1
ENST00000521275.1 ENST00000396774.2 |
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
chr2_-_211036051 | 0.83 |
ENST00000418791.1
ENST00000452086.1 ENST00000281772.9 |
KANSL1L
|
KAT8 regulatory NSL complex subunit 1-like |
chrX_+_105936982 | 0.82 |
ENST00000418562.1
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr2_-_238499131 | 0.82 |
ENST00000538644.1
|
RAB17
|
RAB17, member RAS oncogene family |
chr13_-_52027134 | 0.82 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
chr6_+_7107999 | 0.81 |
ENST00000491191.1
ENST00000379938.2 ENST00000471433.1 |
RREB1
|
ras responsive element binding protein 1 |
chr15_+_45315302 | 0.81 |
ENST00000267814.9
|
SORD
|
sorbitol dehydrogenase |
chr2_+_208576355 | 0.81 |
ENST00000420822.1
ENST00000295414.3 ENST00000339882.5 |
CCNYL1
|
cyclin Y-like 1 |
chr16_-_81129845 | 0.81 |
ENST00000569885.1
ENST00000566566.1 |
GCSH
|
glycine cleavage system protein H (aminomethyl carrier) |
chr9_-_114557207 | 0.81 |
ENST00000374287.3
ENST00000374283.5 |
C9orf84
|
chromosome 9 open reading frame 84 |
chr17_+_62223320 | 0.81 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
chr7_+_116593433 | 0.80 |
ENST00000323984.3
ENST00000393449.1 |
ST7
|
suppression of tumorigenicity 7 |
chr11_+_101981423 | 0.80 |
ENST00000531439.1
|
YAP1
|
Yes-associated protein 1 |
chr1_-_68962744 | 0.80 |
ENST00000525124.1
|
DEPDC1
|
DEP domain containing 1 |
chr3_+_184032419 | 0.80 |
ENST00000352767.3
ENST00000427141.2 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chr17_-_17875688 | 0.80 |
ENST00000379504.3
ENST00000318094.10 ENST00000540946.1 ENST00000542206.1 ENST00000395739.4 ENST00000581396.1 ENST00000535933.1 ENST00000579586.1 |
TOM1L2
|
target of myb1-like 2 (chicken) |
chr2_-_183903133 | 0.79 |
ENST00000361354.4
|
NCKAP1
|
NCK-associated protein 1 |
chr8_+_71581565 | 0.79 |
ENST00000408926.3
ENST00000520030.1 |
XKR9
|
XK, Kell blood group complex subunit-related family, member 9 |
chr7_-_50132860 | 0.78 |
ENST00000046087.2
|
ZPBP
|
zona pellucida binding protein |
chr1_+_92414928 | 0.78 |
ENST00000362005.3
ENST00000370389.2 ENST00000399546.2 ENST00000423434.1 ENST00000394530.3 ENST00000440509.1 |
BRDT
|
bromodomain, testis-specific |
chr13_+_113951532 | 0.78 |
ENST00000332556.4
|
LAMP1
|
lysosomal-associated membrane protein 1 |
chr8_+_103876528 | 0.78 |
ENST00000522939.1
ENST00000524007.1 |
KB-1507C5.2
|
HCG15011, isoform CRA_a; Protein LOC100996457 |
chr2_-_238499303 | 0.78 |
ENST00000409576.1
|
RAB17
|
RAB17, member RAS oncogene family |
chr1_-_230513367 | 0.78 |
ENST00000321327.2
ENST00000525115.1 |
PGBD5
|
piggyBac transposable element derived 5 |
chr17_+_4901199 | 0.77 |
ENST00000320785.5
ENST00000574165.1 |
KIF1C
|
kinesin family member 1C |
chr2_-_238499337 | 0.77 |
ENST00000411462.1
ENST00000409822.1 |
RAB17
|
RAB17, member RAS oncogene family |
chr6_+_125524785 | 0.77 |
ENST00000392482.2
|
TPD52L1
|
tumor protein D52-like 1 |
chr9_-_140444867 | 0.75 |
ENST00000406427.1
|
PNPLA7
|
patatin-like phospholipase domain containing 7 |
chr1_-_154531095 | 0.74 |
ENST00000292211.4
|
UBE2Q1
|
ubiquitin-conjugating enzyme E2Q family member 1 |
chr7_-_50132801 | 0.74 |
ENST00000419417.1
|
ZPBP
|
zona pellucida binding protein |
chr1_-_119869846 | 0.74 |
ENST00000457719.1
|
RP11-418J17.3
|
RP11-418J17.3 |
chr11_-_126081532 | 0.74 |
ENST00000533628.1
ENST00000298317.4 ENST00000532674.1 |
RPUSD4
|
RNA pseudouridylate synthase domain containing 4 |
chr2_-_242254595 | 0.73 |
ENST00000441124.1
ENST00000391976.2 |
HDLBP
|
high density lipoprotein binding protein |
chr2_-_176867501 | 0.73 |
ENST00000535310.1
|
KIAA1715
|
KIAA1715 |
chr1_+_236849754 | 0.73 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
chr7_+_116593568 | 0.72 |
ENST00000446490.1
|
ST7
|
suppression of tumorigenicity 7 |
chr1_-_207119738 | 0.72 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
chr6_-_151773232 | 0.72 |
ENST00000444024.1
ENST00000367303.4 |
RMND1
|
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
chr8_+_75896731 | 0.71 |
ENST00000262207.4
|
CRISPLD1
|
cysteine-rich secretory protein LCCL domain containing 1 |
chr2_-_176866978 | 0.71 |
ENST00000392540.2
ENST00000409660.1 ENST00000544803.1 ENST00000272748.4 |
KIAA1715
|
KIAA1715 |
chr9_-_140444814 | 0.71 |
ENST00000277531.4
|
PNPLA7
|
patatin-like phospholipase domain containing 7 |
chr10_-_13342097 | 0.71 |
ENST00000263038.4
|
PHYH
|
phytanoyl-CoA 2-hydroxylase |
chr7_+_116593292 | 0.71 |
ENST00000393446.2
ENST00000265437.5 ENST00000393451.3 |
ST7
|
suppression of tumorigenicity 7 |
chr1_+_45477819 | 0.71 |
ENST00000246337.4
|
UROD
|
uroporphyrinogen decarboxylase |
chr2_+_208576259 | 0.70 |
ENST00000392209.3
|
CCNYL1
|
cyclin Y-like 1 |
chr9_+_133454943 | 0.70 |
ENST00000319725.9
|
FUBP3
|
far upstream element (FUSE) binding protein 3 |
chr6_+_7107830 | 0.70 |
ENST00000379933.3
|
RREB1
|
ras responsive element binding protein 1 |
chr1_+_9599540 | 0.70 |
ENST00000302692.6
|
SLC25A33
|
solute carrier family 25 (pyrimidine nucleotide carrier), member 33 |
chr1_-_113498616 | 0.69 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
chr1_-_68962782 | 0.69 |
ENST00000456315.2
|
DEPDC1
|
DEP domain containing 1 |
chr1_-_57431679 | 0.69 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
chr1_-_100643765 | 0.69 |
ENST00000370137.1
ENST00000370138.1 ENST00000342895.3 |
LRRC39
|
leucine rich repeat containing 39 |
chr7_+_73242069 | 0.69 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
chr9_-_37576226 | 0.69 |
ENST00000432825.2
|
FBXO10
|
F-box protein 10 |
chr19_-_15236173 | 0.68 |
ENST00000527093.1
|
ILVBL
|
ilvB (bacterial acetolactate synthase)-like |
chr8_+_9009296 | 0.68 |
ENST00000521718.1
|
RP11-10A14.4
|
Uncharacterized protein |
chr12_+_12878829 | 0.68 |
ENST00000326765.6
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr17_-_73975198 | 0.68 |
ENST00000301608.4
ENST00000588176.1 |
ACOX1
|
acyl-CoA oxidase 1, palmitoyl |
chr15_-_76352069 | 0.68 |
ENST00000305435.10
ENST00000563910.1 |
NRG4
|
neuregulin 4 |
chr4_+_76439649 | 0.68 |
ENST00000507557.1
|
THAP6
|
THAP domain containing 6 |
chr1_-_11865982 | 0.67 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr17_-_26684473 | 0.67 |
ENST00000540200.1
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2 |
chr19_-_5720248 | 0.66 |
ENST00000360614.3
|
LONP1
|
lon peptidase 1, mitochondrial |
chr22_-_50699972 | 0.66 |
ENST00000395778.3
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr17_+_17876127 | 0.66 |
ENST00000582416.1
ENST00000313838.8 ENST00000411504.2 ENST00000581264.1 ENST00000399187.1 ENST00000479684.2 ENST00000584166.1 ENST00000585108.1 ENST00000399182.1 ENST00000579977.1 |
LRRC48
|
leucine rich repeat containing 48 |
chr19_-_15236470 | 0.65 |
ENST00000533747.1
ENST00000598709.1 ENST00000534378.1 |
ILVBL
|
ilvB (bacterial acetolactate synthase)-like |
chr11_+_59522837 | 0.65 |
ENST00000437946.2
|
STX3
|
syntaxin 3 |
chr9_+_74764278 | 0.65 |
ENST00000238018.4
ENST00000376989.3 |
GDA
|
guanine deaminase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.9 | 4.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 2.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.6 | 4.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 3.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.6 | 2.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.6 | 2.3 | GO:0009386 | translational attenuation(GO:0009386) |
0.5 | 1.6 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.5 | 2.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.5 | 2.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.5 | 1.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.5 | 1.9 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.4 | 1.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.3 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.4 | 1.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 2.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.1 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.4 | 1.5 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.3 | 0.9 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
0.3 | 0.9 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.3 | 0.9 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.3 | 2.0 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.3 | 1.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 1.9 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 1.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 1.0 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.2 | 1.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 1.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.7 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
0.2 | 0.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 0.4 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
0.2 | 0.6 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 0.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.2 | 0.6 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 | 0.8 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.2 | 0.8 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.2 | 0.6 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.2 | 0.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 0.8 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.5 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.2 | 0.7 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.2 | 0.5 | GO:1903565 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.2 | 2.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 2.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.2 | 0.5 | GO:1901207 | mammary placode formation(GO:0060596) regulation of heart looping(GO:1901207) |
0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 2.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.2 | 4.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 2.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.2 | 0.5 | GO:0050787 | antibiotic metabolic process(GO:0016999) detoxification of mercury ion(GO:0050787) |
0.2 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.6 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.2 | 0.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.9 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.9 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0005985 | sucrose metabolic process(GO:0005985) vacuolar sequestering(GO:0043181) |
0.1 | 1.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 1.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.3 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 1.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.5 | GO:1905123 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
0.1 | 0.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.8 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.6 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.1 | 0.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 5.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.6 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.3 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.1 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 1.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 2.0 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.6 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 0.5 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.1 | 2.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.3 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.1 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.5 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 0.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.3 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.1 | 0.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.7 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.1 | 1.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 1.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.7 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 1.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.1 | 0.5 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 1.0 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0019516 | lactate oxidation(GO:0019516) |
0.1 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 3.3 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 1.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.2 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 1.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.2 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.1 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0072003 | kidney rudiment formation(GO:0072003) |
0.1 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 2.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 1.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.4 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.1 | 0.2 | GO:0061433 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
0.1 | 0.3 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 1.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0070781 | response to biotin(GO:0070781) |
0.0 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:1900368 | pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
0.0 | 0.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.0 | 1.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.8 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.2 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 2.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.5 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.0 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.0 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0032804 | viral protein processing(GO:0019082) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.0 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.1 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.0 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.4 | GO:2001181 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 1.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 1.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.4 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.0 | 1.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 1.4 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.0 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 1.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 5.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 1.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0043201 | response to leucine(GO:0043201) |
0.0 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.4 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.6 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.0 | 0.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 2.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 1.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 1.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 2.1 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.0 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 1.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
0.0 | 0.7 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.0 | 0.1 | GO:0009441 | trophectodermal cell proliferation(GO:0001834) glycolate metabolic process(GO:0009441) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.0 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 1.0 | GO:0007628 | adult walking behavior(GO:0007628) |
0.0 | 0.1 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.4 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.2 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.7 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.5 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.0 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 0.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 2.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 1.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.0 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.0 | 0.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.0 | 0.1 | GO:1902956 | negative regulation of cellular respiration(GO:1901856) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.4 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.0 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.0 | 0.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.0 | 1.1 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.0 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.0 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 1.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.0 | 0.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.1 | GO:0042749 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle(GO:0042745) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.0 | 0.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 1.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.5 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.8 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.4 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 5.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 4.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.9 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.3 | 0.9 | GO:0001534 | radial spoke(GO:0001534) |
0.3 | 0.8 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.3 | 1.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 2.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 4.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.6 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.2 | 1.9 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 1.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 2.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.3 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 0.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.6 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.1 | 0.5 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:0032279 | axonemal microtubule(GO:0005879) asymmetric synapse(GO:0032279) |
0.1 | 1.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 1.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.6 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 4.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 3.5 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 2.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.0 | 1.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.0 | 3.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 1.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 1.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 2.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 2.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.8 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 2.7 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 4.3 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:1990742 | microvesicle(GO:1990742) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 6.5 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 7.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 2.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 1.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.8 | 5.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 2.4 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.6 | 1.9 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.6 | 2.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.5 | 1.6 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.5 | 1.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 1.4 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 1.3 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.4 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.4 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 1.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 2.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 2.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.9 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.9 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.2 | 1.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.6 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.2 | 0.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 1.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 4.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.0 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.2 | 0.6 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.2 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 3.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 2.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.1 | 0.5 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 1.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.6 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.1 | 2.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0031177 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-acetyltransferase activity(GO:0016418) phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 1.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 2.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.2 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.1 | 2.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 2.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.2 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.2 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.2 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.1 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 0.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.1 | 0.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.1 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 3.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.0 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.0 | 0.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 1.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 1.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.2 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.0 | 0.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.0 | 4.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 0.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 1.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 2.3 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.0 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.0 | 0.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 1.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 2.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.0 | 0.4 | GO:0051393 | actinin binding(GO:0042805) alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 1.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 1.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 1.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 1.2 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 1.0 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 3.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 3.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 2.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 4.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 3.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 3.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 5.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 3.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 1.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 2.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 1.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 4.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 3.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 1.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |